Opioid |
|
|
|
Median duration of opioid infusion, h (range) |
47.3 (3.8–120) |
35.2 (0.2–120) |
40.9 (4.5–120) |
Median weighted mean opioid infusion rate: remifentanil and fentanyl, μg kg-1 h-1; morphine, mg kg-1 h-1 (range) |
15.4 (3.0–38.2) |
3.6 (0.1–7.9) |
0.1 (0.0–6.8) |
Propofol |
|
|
|
Number of patients who received a propofol infusion |
76 (90%) |
37 (100%) |
37 (93%) |
Median duration of propofol infusion, h (range) |
24.3 (0.0–118) |
24.5 (0.0–119.4) |
41.7 (0.7–115.3) |
Median weighted mean propofol infusion rate, mg kg-1 h-1 (range) |
1.93 (0.2–68.8) |
2.49 (0.5–11.5) |
2.30 (0.3–18.1) |
Midazolam |
|
|
|
Number of patients who received a midazolam infusion |
30 (36%) |
11 (30%) |
12 (30%) |
Median duration of midazolam infusion, h (range) |
47.3 (0–117.1) |
48.1 (2.3–112.1) |
22.4 (1.8–101.4) |
Median weighted mean midazolam infusion rate, mg kg-1 h-1 (range) |
0.18 (0–17) |
0.11 (0–2.3) |
0.13 (0.1–0.5) |